ARCHIVES

Yarbro Refuses To Seek Core Renewal, Quits Director Post

This article is from The Cancer Letter archive.

Vol. 04 No. 38 | September 22, 1978

Download PDF Visit The Full Archive

Related Articles

In Brief: OMB Still Dragging Its Feet On New Construction Money Schmidt Pressure Gets 70 Slots For NCI

May 23, 1975

Letter to the Editor: IOM Study Welcome For “Omic” Research

October 29, 2010

Zevalin Regimen Better Than Rituximab Alone For NHL

June 29, 2001

NCI CTEP Approved Trials For the Month of July

July 26, 2013

Technology Isolates and Recovers Circulating Liver Tumor Cells

April 27, 2012

Improved Therapies For Cervical Cancer Said To Show Promise In Clinical Trials

March 26, 2004